Univo Pharmaceuticals Ltd. Logo

Univo Pharmaceuticals Ltd.

Vertically integrated biopharma firm developing medical cannabis treatments with a focus on CNS.

UNVO-M | TA

Overview

Corporate Details

ISIN(s):
IL0010935588
LEI:
Country:
Israel
Address:
30 Haarbaa TEL AVIV-JAFFA, Central District, 6473926 Tel Aviv
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Univo Pharmaceuticals Ltd. is a vertically integrated biopharmaceutical company operating in the medical cannabis sector. The company manages the entire value chain, from research, development, and cultivation to the manufacturing and distribution of cannabis-based medical products. By maintaining full control over its processes, Univo aims to develop high-quality solutions to improve patient health and quality of life. The firm has a particular focus on developing treatments for the central nervous system (CNS) and operates a significant distribution network, supplying its products to numerous pharmacies.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2023-08-10 19:49
Regulatory News Service
ISA informed TASE that the company is a "shell company", the company's securiti…
Hebrew (modern) 81.2 KB
2022-12-18 14:53
Regulatory News Service
Trading in the company's shares has been suspended as of today, on December 28…
Hebrew (modern) 80.0 KB
2022-12-12 11:07
Regulatory News Service
BOND SERIES A-TRADING SUSPENSION FOLLOWING TRUSTEE ANNOUNCEMENT REGARDING IMMED…
Hebrew (modern) 77.4 KB
2022-07-21 19:42
Regulatory News Service
Discontinuation of Market Making, If another market maker will not start to op…
Hebrew (modern) 255.5 KB

Automate Your Workflow. Get a real-time feed of all Univo Pharmaceuticals Ltd. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Univo Pharmaceuticals Ltd.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Univo Pharmaceuticals Ltd. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
Aptahem AB Logo
Develops RNA aptamers to treat acute, life-threatening conditions like sepsis.
Sweden APTA
Aptamer Sciences Inc Logo
Develops aptamer-based therapeutics and diagnostics for oncology and solid tumors.
South Korea 291650
Arctic Bioscience Logo
Develops pharma & nutra ingredients from marine lipids for autoimmune & wellness applications.
Norway ABS
ArcticZymes Technologies Logo
Develops novel enzymes from Arctic organisms for diagnostics, therapeutics, and biopharma.
Norway AZT
ARECOR THERAPEUTICS PLC Logo
Biopharma firm enhancing drugs via reformulation for diabetes and pharmaceutical partners.
United Kingdom AREC
argenx SE Logo
Develops first-in-class antibody therapies for severe autoimmune diseases.
Netherlands 1AE
AroCell AB Logo
Develops and markets diagnostic tests for monitoring cancer and bacterial diseases.
Sweden AROC
Ascelia Pharma Logo
Develops novel drugs for rare oncology, including an oral MRI contrast agent for cancer patients.
Sweden ACE
Specializes in hormone drugs for OB/GYN, urology, internal medicine, and animal health.
Japan 4886
Astellas Pharma Inc. Logo
A global pharmaceutical company developing innovative medicines for unmet needs, focusing on oncology.
Japan 4503

Talk to a Data Expert

Have a question? We'll get back to you promptly.